Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized...

Cancer Biotherapy & Radiopharmaceuticals 2010 / 02 Vol. 25; Iss. 1

Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)

Forero-Torres, Andres, Shah, Jatin, Wood, Tina, Posey, James, Carlisle, Ronda, Copigneaux, Catherine, Luo, Feng (Roger), Wojtowicz-Praga, Slawomir, Percent, Ivor, Saleh, Mansoor
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Language:
english
Journal:
Cancer Biotherapy & Radiopharmaceuticals
DOI:
10.1089/cbr.2009.0673
Date:
February, 2010
File:
PDF, 288 KB
english, 2010
Conversion to is in progress
Conversion to is failed